ORGANON REMERON IS FIRST ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANT RECOMMENDED BY ADVISORY COMMITTEE; LABELING SHOULD NOTE NEUTROPENIA RISK
Executive Summary
Organon's Remeron (mirtazapine) is the first alpha2-receptor antagonist recommended for approval for the treatment of depression by FDA's Psychopharmacologic Drugs Advisory Committee. On two unanimous votes Oct. 16 the committee agreed Remeron (NDA 20-415) is safe and effective for the requested indication.